64 completed, 6 terminated, 6 unknown, 4 recruiting. 88 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 88 | Completed 64, Terminated 6, Unknown 6, Recruiting 4, Withdrawn 4, Not yet recruiting 2, Active not recruiting 1, Enrolling by invitation 1 |
Follow Bupropion: new trials by email Literature Review of Bupropion trials Research Report on Bupropion
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Smoking Cessation Medication And Rewards Using a Teamlet to Treat Tobacco Use Disorder (SMARTTT 2.0) Among Persons With HIV: A Multi-site Hybrid Type 2 Effectiveness-implementation Trial nicotine patch, nicotine gum, nicotine lozenge, varenicline, bupropion, Multi-target Contingency Management, Teamlet booster - Tobacco Use Disorder/Cigarette Smoking, HIV | Phase 4 | Not yet recruiting | Yale University | 794 | 2027-09-30 | 2026-09-23 |
| Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive Disorder bupropion hydrobromide, Placebo - Major Depressive Disorder | Phase 4 | Not yet recruiting | Bausch Health Americas, Inc. | 246 | 2027-07-01 | 2026-09-29 |
| Improving Efficacity of Sleeve Gastrectomy With Naltrexone/Bupropion Extended-release Tablet Naltrexone/Bupropion, Placebo - Obesity; Drug, Obesity, Morbid | Phase 4 | Recruiting | Laval University | 108 | 2025-06-04 | 2025-08-08 |
| Effect of an Early Time Restricted Eating Mediterranean Diet Compared to Naltrexone/Bupropion on Liver Fibrosis in People With Cardiometabolic Risk Factors in a Hospital Outpatient Clinic (MEDFAST-study) early time restricted Mediterranean diet, Mysimba - Diabetes Mellitus, Type 2, Liver Fibrosis | Phase 4 | Enrolling by invitation | Carmen Dietvorst | 70 | 2025-04-14 | 2026-04-21 |
| Effectiveness of Combined Tobacco Treatment in Hospitalized Subjects Bupropion, Nicotine replacement therapy (Nicotine patches) - Tobacco Smoking, Tobacco Withdrawal | Phase 4 | Unknown | National Institute of Respiratory Diseases, Mexico | 134 | 2024-01-15 | 2024-02-23 |
| A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms AXS-05, Bupropion - Major Depressive Disorder | Phase 4 | Recruiting | Axsome Therapeutics, Inc. | 350 | 2023-12-27 | 2025-01-23 |
| Integrating Tobacco Use Cessation Into HIV Care and Treatment in Kisumu County, Kenya Tobacco Use Cessation Counselling Sessions, Bupropion, Nicotine patch - Tobacco Use Cessation, Tobacco Use | Phase 4 | Completed | University of California, San Francisco | 580 | 2023-05-16 | 2025-07-02 |
| A Research Study Comparing Wegovy to Other Weight Management Drugs in People Living With Obesity in America Semaglutide, Orlistat, Phentermine/Topiramate - Obesity | Phase 4 | Completed | Novo Nordisk A/S | 500 | 2023-01-19 | 2026-01-14 |
| Reward-specific Changes of the Chemical Messenger Dopamine in the Brain of Healthy and Depressed People WELLBUTRIN SR (Bupropion HCI) Sustained-Release Tablets, 150 mg; GlaxoSmithKline, Cipralex (escitalopram) - Major Depressive Disorder (MDD) | Phase 4 | Recruiting | Medical University of Vienna | 120 | 2022-12-01 | 2024-11-05 |
| SMART Trial to Predict Anhedonia Response to Antidepressant Treatment Sertraline, Bupropion - Major Depressive Disorder | Phase 4 | Completed | Mclean Hospital | 57 | 2022-09-30 | 2026-10-30 |
| Predictors of Cognitive Outcomes in Geriatric Depression Sertraline, bupropion, desvenlafaxine - Major Depressive Disorder, Neuroticism | Phase 4 | Active not recruiting | David Steffens | 75 | 2021-09-28 | 2026-05-22 |
| Naltrexone/Bupropion (Mysimba) to Optimize Weight Outcomes After Obesity Surgery Naltrexone/bupropion, Lifestyle - Obesity | Phase 4 | Withdrawn | Oslo University Hospital | 2020-11-01 | 2021-03-01 | |
| Leveraging EEG for Antidepressant Prediction With Duloxetine and Bupropion Duloxetine, Bupropion - Major Depressive Disorder | Phase 4 | Withdrawn | Alto Neuroscience | 2020-10-15 | 2020-10-19 | |
| Bupropion Versus Escitalopram on Reward Circuitry and Motivational Deficits Bupropion XL, Escitalopram - Major Depression | Phase 4 | Completed | Emory University | 18 | 2020-09-23 | 2023-12-29 |
| Nicotine Replacement Therapy, Counseling, Varenicline, and Bupropion for Smoking Cessation, the PISCES I Trial Bupropion Hydrochloride Controlled-release, Nicotine Replacement, Questionnaire Administration - Cigarette Smoking-Related Carcinoma | Phase 4 | Recruiting | M.D. Anderson Cancer Center | 2010 | 2020-08-04 | 2026-10-07 |
| A Smart Approach to Treating Tobacco Use Disorder in Persons Living With HIV Nicotine patch, nicotine gum, nicotine nasal spray, nicotine inhaler, Varenicline or bupropion, Contingency Management - Tobacco Use Cessation | Phase 4 | Completed | Yale University | 323 | 2020-07-27 | 2026-01-05 |
| Mobile Evidence-Based Smoking Cessation for Veterans Living With HIV (MESH) Bupropion, Varenicline, Cognitive Behavioral Therapy - Human Immunodeficiency Virus, Smoking | Phase 4 | Completed | VA Office of Research and Development | 12 | 2019-11-18 | 2023-07-27 |
| CPT-SMART for Treatment of PTSD and Cigarette Smoking Smoking Cessation Cognitive Behavioral Therapy (CBT), Bupropion, Cognitive Processing Therapy - Smoking, Stress Disorders, Post-Traumatic | Phase 4 | Completed | VA Office of Research and Development | 115 | 2019-11-07 | 2026-07-02 |
| RCT of Brain Longitudinal Biomarker Study (OPT-Neuro RCT) Aripiprazole Augmentation, Bupropion Augmentation, Switch to bupropion - Depression, Dementia | Phase 4 | Completed | Centre for Addiction and Mental Health | 87 | 2019-08-01 | 2024-11-25 |
| Promoting Enhanced Pharmacotherapy Choice Through Immunomarkers Evaluation in Depression Escitalopram, Bupropion - Depression | Phase 4 | Terminated | University of Texas Southwestern Medical Center | 18 | 2019-07-23 | 2023-04-18 |
Showing 20 of 88. Sign in to see all of them.
Depressive Disorder, Major (30) · Smoking Cessation (22) · Depression (20) · Tobacco Use Disorder (18) · Smoking (7) · Schizophrenia (6) · Dysthymic Disorder (5) · Obesity (5) · Cigarette Smoking (4) · Tobacco Use Cessation (4) · Mental Disorders (3) · Psychotic Disorders (3) · Alcoholism (2) · Bipolar Disorder (2) · Depressive Disorder (2)
New York State Psychiatric Institute (9) · Centre for Addiction and Mental Health (3) · Duke University (3) · Shanghai Mental Health Center (3) · Stanford University (3) · University of Wisconsin, Madison (3) · VA Office of Research and Development (3) · Yale University (3) · Emory University (2) · Indiana University (2) · National Institute on Drug Abuse (NIDA) (2) · North Suffolk Mental Health Association (2) · Pfizer (2) · University of California, San Francisco (2) · University of Colorado, Denver (2)
United States (61) · Canada (11) · South Korea (4) · Brazil (3) · Mexico (3) · Argentina (2) · Australia (2) · Bulgaria (2) · Chile (2) · China (2) · Denmark (2) · Finland (2) · Germany (2) · Netherlands (2) · New Zealand (2)
A Eden Evins, MD, MPH (3) · E. Jennifer Edelman, MD, MHS (2) · Jonathan W. Stewart, M.D. (2) · Jonathan W. Stewart, MD. (2) · Peter Selby, MD, MHSc (2) · Amit Anand, MD (1) · Andrea H. Weinberger, Ph.D. (1) · Andrew Miller, MD (1) · Andrew Pipe, MD (1) · Angela Moore (1) · Anna Lembke, MD (1) · Annelies E Jacobs, PHD (1) · Aristotle Voineskos, MD (1) · Boadie W Dunlop, MD (1)
PMID 37230961, PMID 12095672, PMID 12439223, PMID 14982685, PMID 15138759, PMID 15203809, PMID 15631608, PMID 16036283, PMID 16123753, PMID 16157462, PMID 16203030, PMID 17632223, PMID 17763111, PMID 19349630, PMID 19820552, PMID 20008701, PMID 20236788, PMID 20308641, PMID 20430565, PMID 21266057, PMID 21775497, PMID 21885891, PMID 21993207, PMID 22172440, PMID 22241828, PMID 22321019, PMID 22496918, PMID 22608375, PMID 22949583, PMID 23669629, PMID 23733379, PMID 24107760, PMID 24485847, PMID 24893290, PMID 24938369, PMID 25295437, PMID 25615566, PMID 25867447, PMID 26429100, PMID 27116918, PMID 27890648, PMID 28239942, PMID 29251951, PMID 29439084, PMID 29508470, PMID 29563871, PMID 29630702, PMID 30847828, PMID 30874290, PMID 31099895
K23MH076049 (2), P50DA019706 (2), 2019 (1), K23MH001828 (1), P20AA015630 (1), R01CA091912 (1), R01CA243910 (1), R01DA004174 (1), R01DA017441 (1), R01DA022284 (1), R01DA030998 (1), R01GM078501 (1), R01MH068391 (1), R01MH076961 (1), R01MH085925 (1)